Moxetumomab pasudotox-tdfk Intravenous and Niacin Controlled-Release Capsules and Controlled-Release Tablets
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Niacin Controlled-Release Capsules and Controlled-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: niacin
Brand name: B-3-50, B3-500-Gr, Niacin SR, Niacor, Niaspan ER, Slo-Niacin
Synonyms: Niacin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Niacin SR
- Moxetumomab pasudotox-tdfk Intravenous-Niacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Niacinamide
- Moxetumomab pasudotox-tdfk Intravenous-Niacinamide Extended-Release Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Niacor
- Moxetumomab pasudotox-tdfk Intravenous-Niaspan
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Moxifloxacin
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Moxifloxacin (Systemic)
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Moxifloxacin Hydrochloride
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Moxifloxacin Injection
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Moxifloxacin Intravenous
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Moxifloxacin Tablets